Depressive symptoms, risk of abandonment and poor adherence to treatment in patients with sensitive tuberculosis in a health center in Lima, 2016-2020
DOI:
https://doi.org/10.20453/rnp.v84i4.4135Keywords:
Tuberculosis, depression, abandonment, adherence, treatmentAbstract
Objective: To determine if the presence of depressive symptoms is a factor associated with abandonment or poor adherence to treatment in sensitive TB patients in a Lima health center, between 2016-2020. Materials and methods: A non-experimental, analytical, cohort, retrospective study carried out. At the Centro de Salud Materno- Infantil Buenos Aires de Villa. The information was collected from the medical records, a cohort risk estimate (Relative Risk) and levels of statistical significance were performed, with the SPSS Statistics 25 program. Results: The frequency of treatment abandonment was 18.3% (n = 28), poor adherence 42.5% (n = 65) and depression 53.6% (n = 82). Depressive symptoms were associated with treatment abandonment [RR = 2.16; 95% CI (1.01-4.60)] and poor treatment adherence [RR = 2.09; 95% CI (1.36-3.22)]. Conclusions: Depression is a risk factor significantly associated with abandonment and poor adherence to treatment in patients with sensitive tuberculosis.
References
Organización Mundial de la Salud. Depresión. Ginebra: Organización Mundial de la Salud; 2020. (Citado 30 de enero del 2020). Disponible en: https://www.who.int/es/news-room/fact-sheets/ detail/depression
Kaplan H. Compendio de Psiquiatría. Barcelona: Salvatierra; 2016.
Goldstein CM, Gathright EC, Gunstad J, et al. Depressive symptoms moderate the relationship between medication regimen complexity and objectively measured medication adherence in adults with heart failure. J Behav Med. 2017; 40: 602–611. doi: 10.1007/s10865-017-9829-z
Furin J, Cox H, Pai M. Tuberculosis. Lancet. 2019;393(10181):1642-1656. DOI: 10.1016/S0140- 6736(19)30308-3
World Health Organization. Global tuberculosis report 2019. Ginebra: World Health Organization; 2019. (Citado 30 de enero del 2020). Disponible en: https://apps.who.int/iris/bitstream/handle/10665/ 329368/9789241565714-eng.pdf
Organización Mundial de la Salud. Adherencia a los tratamientos a largo plazo: Pruebas para la acción. Ginebra: Organización Mundial de la Salud; 2004. (Citado 30 de enero del 2020). Disponible en: https:// www.paho.org/Spanish/AD/DPC/NC/nc-adherencia. pdf.
Peltzer K, Naidoo P, Matseke G, Louw J, Mchunu G, Tutshana B. Prevalence of psychological distress and associated factors in tuberculosis patients in public primary care clinics in South Africa. BMC Psychiatry. 2012;12(1):89. Doi: 10.1186/1471-244X- 12-86.
Alarcón V, Alarcón E, Figueroa C, Mendoza-Ticona A. Tuberculosis in Peru: epidemiological situation, progress and challenges for its control. Rev Peru Med Doi: 10.17843/rpmesp.2017.342.2384
Zevallos M. Factores asociados al Abandono del tratamiento Antituberculoso, esquema I, en la Red de salud San Juan de Lurigancho.Tesis para optar el grado de Maestro en Control de Enfermedades Infecciosas y Tropicales. Lima Perú: Universidad Peruana Cayetano Heredia; 2017. (Citado 30 de enero del 2020). Disponible en: http://repositorio.upch.edu.pe/ handle/upch/1030
Duko B, Gebeyehu A, Ayano G. Prevalence and correlates of depression and anxiety among patients with tuberculosis at Wolaita Sodo University Hospital and Sodo Health Center, WolaitaSodo, South Ethiopia, Cross sectional study. BMC Psychiatry. 2015; 15:214. Doi: 10.1186/s12888-015-0598-3.
Aamir S, Aisha. Co-morbid anxiety and depression among pulmonary tuberculosis patients. J Coll Physicians Surg Pak. 2010; 20(10):703-4. doi: 10.2010/JCPSP.703704
Kehbila J, Ekabe CJ, Aminde LN, Noubiap JJ, Fon PN, Monekosso GL. Prevalence and correlates of depressive symptoms in adult patients with pulmonary tuberculosis in the Southwest Region of Cameroon. Infect Dis Poverty. 2016; 5(1):51. Doi: 10.1186/s40249-016-0145-6.
Molla A, Mekuriaw B, Kerebih H. Depression and associated factors among patients with tuberculosis in Ethiopia: a cross-sectional study. Neuropsychiatric Disease and Treatment. 2019;15: 1887–1893. Doi: 10.2147/NDT.S208361
Doherty AM, Kelly J, McDonald C, O’Dywer AM, Keane J, Cooney J. A review of the interplay between tuberculosis and mental health. Gen Hosp Psychiatry. 2013;35(4):398-406. Doi: 10.1016/j. genhosppsych.2013.03.018
Ambaw F, Mayston R, Hanlon C, Medhin G, Alem A. Untreated depression and tuberculosis treatment outcomes, quality of life and disability, Ethiopia. Bull World Health Organ. 2018; 96(4):243. Doi:10.2471/BLT.17.206417
Neves LA, Reis RK, Gir E. Adesão ao tratamento por indivíduos com a co-infecção HIV/tuberculose: revisão integrativa da literatura. Rev Esc Enferm USP. 2010;44(4):1135-41. Doi: 10.1590/s0080- 62342010000400041
Llanos-Tejada F, Ponce-Chang Cr. Depresión y adherencia en personas afectadas con tuberculosis: Una exploración preliminar de datos. Rev Neuropsiquiatr. 2019; 82(2): 104-109. Doi: 10.20453/ rnp.v82i2.3536.
Morales H. Influencia de la depresión sobre la adherencia al tratamiento en pacientes TB-MDR de la Red Almenara. Revista de la Facultad de Medicina Humana de la Universidad Ricardo Palma. 2015;1: 16-22. 19. Ruiz P, Cachay R, De la Flor A, Schwalb A, Ugarte C. Association between tuberculosis and depression on negative outcomes of tuberculosis treatment: A systematic review and meta-analysis. PLoS
ne. 2020;15(1): e0227472. Doi: 10.1371/journal. pone.0227472
Maldonado A, Lozano L. Influencia de la depresión sobre la adherencia al tratamiento en pacientes con tuberculosis multidrogoresistente en el Hospital Regional de Pucallpa en el periodo Enero 2014- Diciembre 2015. Tesis Pregrado. Pucallpa: Universidad Nacional de Ucayali; 2016. (Citado 30 de enero del 2020). Disponible en: http://repositorio. unu.edu.pe/bitstream/handle/UNU/1611/ 000002027T.pdf?sequence=1&isAllowed=y.
Faria N, Mota M, Marins R, Barbosa A, Soares L, Oliveira A, Souto J. Differences between risk factors associated with tuberculosis treatment abandonment and mortality. Pulm Med. 2015; 2015:546106. Doi: 10.1155/2015/546106
Herrero M, Arrossi S, Ramos S, Braga J. Social determinants of nonadherence to tuberculosis treatment in Buenos Aires, Argentina. Cad SaúdePública. 2015; 31(9): 1983-1994. (Citado 15 de diciembre del 2020). Disponible en: http://www. scielo.br/scielo.php?script=sci_arttext&pid=S0102- 311X2015000901983&lng=en.
Cáceres F, Orozco L. Incidencia y factores asociados al abandono del tratamiento antituberculoso. Biomédica. 2007; 27(4): 498-504. (Citado 15 de diciembre del 2020). Disponible en: http://www. scielo.org.co/scielo.php?script=sci_arttext&pid= S0120-41572007000400005&lng=en
Rivera O, Benites S, Mendigure J, Bonilla C. Abandono del tratamiento en tuberculosis multirresistente: factores asociados en una región con alta carga de la enfermedad en Perú. Biomédica. 2019; 39(2): 44- 57. Doi: 10.7705/biomedica.v39i3.4564.
Soares M, Amaral N, Zacarias A, Ribeiro L. Sociodemographic, clinical and epidemiological aspects of Tuberculosis treatment abandonment in Pernambuco, Brazil, 2001-2014. Epidemiol Serv Saude. 2017; 26(2):369-378. Doi: 10.5123/S1679- 49742017000200014.
Torres Z, Herrera T. Perfil del paciente con tuberculosis que abandona el tratamiento en Chile: profile of patients in Chile. Rev chil enferm respir. 2015; 31(1): 52-57. (Citado 15 de diciembre del 2020). Disponible en: https://scielo. conicyt.cl/scielo.php?script=sci_arttext&pid=S0717- 73482015000100008&lng=es.Recibido: 02/02/2021Aceptado: 23/12/2021
RNP is distributed under a 